Emerging Legal Terrain: IP Risks from AI's Role In Drug Discovery

Most firms are aiming their newest tools at the work they already do — pouring their most powerful technology into running the same tasks a little faster. But when everyone automates the same tasks at once, no one pulls ahead. That reaches the future a little faster while leaving a firm’s largest opportunity untouched — and that opportunity isn’t doing more of the existing work, but transforming how the high-value work gets done.

AI is becoming both an accelerant and a distraction for cybersecurity. In many respects, AI is acting as a stress test for existing security operations by exposing how difficult many organizations still find it to enforce basic controls consistently at scale.

Artificial intelligence is rapidly embedding itself into legal workflows, but much of the conversation treats all use cases as if they carry the same level of risk, even if they do not. The more useful question is not whether AI works, but where it can be safely applied and where it cannot.